Core Total Current Assets vs Cash Analysis
CLB Stock | USD 18.04 0.14 0.78% |
Core Laboratories financial indicator trend analysis is way more than just evaluating Core Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Core Laboratories is a good investment. Please check the relationship between Core Laboratories Total Current Assets and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Total Current Assets vs Cash
Total Current Assets vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Core Laboratories Total Current Assets account and Cash. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Core Laboratories' Total Current Assets and Cash is 0.82. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Cash in the same time period over historical financial statements of Core Laboratories NV, assuming nothing else is changed. The correlation between historical values of Core Laboratories' Total Current Assets and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Core Laboratories NV are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Current Assets i.e., Core Laboratories' Total Current Assets and Cash go up and down completely randomly.
Correlation Coefficient | 0.82 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Cash
Cash refers to the most liquid asset of Core Laboratories, which is listed under current asset account on Core Laboratories NV balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Core Laboratories customers. The amounts must be unrestricted with restricted cash listed in a different Core Laboratories account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Core Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. The current year's Tax Provision is expected to grow to about 10.8 M, whereas Selling General Administrative is forecasted to decline to about 34.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 83.8M | 78.9M | 94.0M | 171.1M | Total Revenue | 470.3M | 489.7M | 509.8M | 619.3M |
Core Laboratories fundamental ratios Correlations
Click cells to compare fundamentals
Core Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Core Laboratories fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 774.7M | 568.6M | 580.9M | 578.4M | 586.4M | 550.2M | |
Short Long Term Debt Total | 381.8M | 327.0M | 250.3M | 222.4M | 215.4M | 217.2M | |
Other Current Liab | 50.8M | 49.8M | 40.9M | 39.6M | 39.7M | 47.9M | |
Total Current Liabilities | 111.6M | 89.8M | 90.8M | 103.1M | 88.1M | 100.6M | |
Total Stockholder Equity | 182.1M | 75.6M | 161.0M | 189.0M | 224.8M | 131.8M | |
Property Plant And Equipment Net | 199.2M | 181.7M | 172.3M | 157.4M | 153.5M | 120.1M | |
Net Debt | 370.7M | 313.2M | 232.6M | 207.0M | 200.3M | 187.0M | |
Retained Earnings | 160.5M | 50.5M | 68.3M | 85.9M | 120.8M | 194.2M | |
Accounts Payable | 35.6M | 23.0M | 29.7M | 45.8M | 33.5M | 35.9M | |
Cash | 11.1M | 13.8M | 17.7M | 15.4M | 15.1M | 14.4M | |
Non Current Assets Total | 553.4M | 402.7M | 391.8M | 366.7M | 363.3M | 325.2M | |
Non Currrent Assets Other | (71.3M) | (76.9M) | (74.6M) | (73.0M) | 29.4M | 30.8M | |
Cash And Short Term Investments | 11.1M | 13.8M | 17.7M | 15.4M | 15.1M | 14.4M | |
Net Receivables | 131.6M | 83.2M | 96.8M | 106.9M | 123.1M | 129.1M | |
Common Stock Shares Outstanding | 44.6M | 45.0M | 46.7M | 46.8M | 47.5M | 40.8M | |
Liabilities And Stockholders Equity | 774.7M | 568.6M | 580.9M | 578.4M | 586.4M | 550.2M | |
Non Current Liabilities Total | 480.9M | 403.3M | 329.1M | 286.3M | 268.5M | 267.2M | |
Inventory | 50.2M | 38.2M | 45.4M | 60.4M | 71.7M | 39.7M | |
Other Current Assets | 28.4M | 30.7M | 29.1M | 28.9M | 13.2M | 26.0M | |
Other Stockholder Equity | 26.8M | 31.2M | 101.6M | 105.6M | 108.6M | 114.0M | |
Total Liab | 592.5M | 493.0M | 419.9M | 389.4M | 356.6M | 367.8M | |
Property Plant And Equipment Gross | 199.2M | 181.7M | 172.3M | 157.4M | 181.0M | 118.3M | |
Total Current Assets | 221.2M | 165.8M | 189.1M | 211.7M | 223.1M | 225.0M | |
Accumulated Other Comprehensive Income | (6.3M) | (7.2M) | (10.1M) | (3.8M) | (5.0M) | (5.2M) | |
Short Term Debt | 11.8M | 11.4M | 12.3M | 11.7M | 10.2M | 14.1M | |
Intangible Assets | 17.5M | 8.6M | 8.1M | 7.5M | 6.9M | 6.6M | |
Other Liab | 109.9M | 87.7M | 91.1M | 75.6M | 86.9M | 66.4M | |
Other Assets | 119.4M | 179.4M | 107.7M | 102.3M | 1.0 | 0.95 | |
Long Term Debt | 305.3M | 259.4M | 188.6M | 172.4M | 198.2M | 229.8M | |
Property Plant Equipment | 123.5M | 115.3M | 172.3M | 157.4M | 181.0M | 126.1M | |
Current Deferred Revenue | 13.4M | 5.5M | 7.8M | 5.9M | 4.8M | 4.5M | |
Treasury Stock | (29.4M) | (14.1M) | (4.1M) | (1.4M) | (1.6M) | (1.6M) | |
Net Tangible Assets | 11.7M | 19.6M | (58.5M) | 115.6M | 104.1M | 109.3M | |
Noncontrolling Interest In Consolidated Entity | 4.3M | 4.1M | 4.6M | 4.7M | 5.4M | 4.6M | |
Retained Earnings Total Equity | 160.5M | 50.5M | 68.3M | 85.9M | 77.4M | 73.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.374 | Dividend Share 0.04 | Earnings Share 0.51 | Revenue Per Share 10.935 | Quarterly Revenue Growth 0.01 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.